Redox Extends Capabilities of Salesforce Health Cloud with Patient Data from Electronic Medical Records

Redox has announced it is extending the capabilities of Salesforce Health Cloud with its EMR integration engine.

Redox provides a modern API solution for clinical integration with electronic medical record (EMR) systems. The addition of Redox to the Health Cloud product provides streamlined sharing of clinical data and a comprehensive view of patient conditions and clinical events. Health Cloud is generally available for purchase today, giving healthcare providers new ways to make smarter care decisions, engage with patients across their caregiver networks and manage patient data. Redox joins Salesforce as a Health Cloud launch partner at the Healthcare Information and Management Systems Society (HIMSS16) Conference in Las Vegas.

“We are devoted to accelerating the adoption of great technology in healthcare. We believe Salesforce Health Cloud represents a great step for the industry and look forward to helping the solution positively impact the maximum number of lives,” said Niko Skievaski, Co-founder & President, Redox. “Health Cloud brings together data from many sources and presents a comprehensive view of the patient. Accessing data from the electronic medical record real-time through a modern infrastructure is an integral piece of this puzzle and we are proud to partner with Salesforce to deliver robust EMR integrations.”

“We live in the age of the customer, and patients now expect personalized and engaging experiences with their healthcare providers,” said Joshua Newman, MD, Chief Medical Officer, GM, Salesforce Healthcare and Life Sciences. “Health Cloud is all about building stronger patient relationships, and Redox is a valuable part of our journey towards creating a modern healthcare platform for patients, doctors, and everyone else involved in care.”

Redox Key Features

Redox integrates with electronic medical records and standardizes disparate data formats to consistent JSON data models. Partners establish connectivity with Redox once and are then able to send and receive data with any health system or digital health application through a modern web service API. Redox provides robust maintenance and support of connections ensuring data flows appropriately and allows organizations to focus on core functions.

Read more...

Blood Pressure Monitoring Testing Market is Expected to Reach USD 3.7 Billion Globally in 2019

According to a new market report published by Transparency Market Research "Blood Pressure Monitoring Testing Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global blood pressure monitoring testing market was valued at USD 1,713.3 million in 2012 and is estimated to reach a market worth USD 3,661.3 million in 2019 at a CAGR of 11.5% from 2013 to 2019.

Hypertension is one of the leading causes of heart diseases and strokes globally. The exact cause of high blood pressure is unknown but it develops with changing lifestyle and growing age. Rise in prevalence of high/low blood pressure is attributed to sedentary lifestyle, lack of physical activity geriatric population and rising stress. Blood pressure monitors are widely used by physicians in clinics, hospitals and even by patients themselves at home for self-monitoring. With the rising incidence rate of hypertension there is an increase in awareness about monitoring techniques, creating a substantial rise in demand for blood pressure monitoring devices.

There are various social, behavioral and metabolic factors that determine and contribute to the development of high blood pressure (hypertension). The blood pressure monitoring and testing market can be segmented as sphygmomanometers, automated blood pressure monitors, ambulatory blood pressure monitors, blood pressure transducers, and blood pressure instrument accessories. Manufacturers are coming up with new and innovative digital blood pressure monitoring devices that are easy to use and provide accurate readings instantly.

The digital sphygmomanometers market is expected to grow at a faster rate compared to other types of sphygmomanometers (mercury and aneroid) as they are easier to use and provide comparatively accurate results. Technological advancement is another important factor responsible for the growth of this market. mHealth is the new technological breakthrough in the healthcare market, where ubiquitous mobile technology supports the growth and successful implementation of mobile technology in healthcare industry. Prevention and early detection are the important factors for regular monitoring. Hence, mobile and portable devices would help the patient population to monitor their parameters. Devices when connected wirelessly would automatically transmit the required data of the patients to healthcare professionals. The North American market accounted for the largest share of more than 40% in 2012 and is expected to dominate the market during the forecasted period.

This accelerated growth is mainly due to rising population, sedentary lifestyle, increasing stress and changing lifestyles. It is estimated that one in every three Americans suffer from hypertension and an individual is three times more susceptible to heart diseases when suffering from hypertension.

The Asia-Pacific region is expected to grow at the highest CAGR of over 12% from 2013 to 2019, due to expanding population base coupled with a sedentary lifestyle, triggering growth in this region. Prevalence of high blood pressure is more rampant in low or middle income countries as compared to high-income countries due to a growing number of people with undiagnosed, uncontrolled and untreated high blood pressure.

Read more...
Subscribe to this RSS feed